AlphaFold predicted structure
IL1R1 · P14778

Mean pLDDT
83.9/ 100
Confident
569 residues
Confidence breakdown
- Very high(≥ 90)51%
- Confident(70–90)33%
- Low(50–70)11%
- Very low(< 50)6%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
interleukin 1 receptor type 1
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Primary immunodeficiency or monogenic inflammatory bowel disease
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedFamilial Meniere Disease
rheumatoid arthritis
Ascending aortic dissection
asthma
inflammatory bowel disease
COVID-19
CINCA syndrome
immune system disorder
neurodegenerative disease
gout
chronic recurrent multifocal osteomyelitis 3
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Interleukin-1 receptor type 1
Receptor for IL1A, IL1B and IL1RN (PubMed:2950091, PubMed:37315560). After binding to interleukin-1 associates with the coreceptor IL1RAP to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B, MAPK and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Binds ligands with comparable affinity and binding of antagonist IL1RN prevents association with IL1RAP to form a signaling complex. Involved in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (PubMed:10653850)
IL1R1 · P14778

Mean pLDDT
83.9/ 100
Confident
569 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0